Kanara cultivates plant cells in vitro to produce high‑purity extracts such as resveratrol, polyphenols, biofuels, and pharmaceuticals, replacing traditional agriculture. Using modular, automated bioreactors, the company generates sterile, uniform powders with significantly lower water, energy, and CO₂ usage, delivering cost‑effective, scalable bio‑manufacturing for the life‑science and agri‑tech markets.
Funding
Funding not disclosed
Founders
Product
Problem
Producing plant‑derived active compounds through traditional agriculture requires large land areas, extensive water and energy inputs, and results in variable product quality and high CO₂ emissions. Scaling such production to meet growing demand for resveratrol, polyphenols, biofuels and pharmaceuticals is therefore costly and environmentally burdensome.
Solution
Kanara replaces whole‑plant cultivation with in‑vitro plant cell culture using modular, automated bioreactors. Selected high‑yield varieties are propagated as sterile stem‑cell‑like cultures, which are then grown in closed bioreactor systems that can be scaled up or down on demand. The process generates concentrated extracts of target metabolites in powder form, delivering uniform, sterile batches while consuming far less water, energy and space. By eliminating field cultivation, the approach reduces CO₂ emissions and lowers the cost per gram of active ingredient, providing a more sustainable supply chain for high‑value plant metabolites.
Target Audience
Primary customers are manufacturers of nutraceuticals, cosmetics, biofuel producers and pharmaceutical companies that require consistent, high‑purity plant‑derived active ingredients at scale.
Features
- Modular, automated bioreactor platforms that support iterative short‑cycle in‑vitro growth for rapid scale‑up
- Genetic‑modification‑free stem cell culture derived from selected high‑producing plant varieties
- Closed, sterile production environment delivering uniform powder extracts with high metabolite concentration
- Resource‑efficient operation with up to 90 % reduction in water and energy use compared to field farming
- Flexible production capacity that can be adjusted to match market demand, minimizing inventory waste
- Integrated downstream processing that converts cultured cells directly into dry, stable active‑ingredient powders